Biomarkers for prostate cancer and methods using the same

Details for Australian Patent Application No. 2007299846 (hide)

Owner Metabolon, Inc.

Inventors Mitchell, Matthew W.; Berger, Alvin; Lawton, Kay, A.

Agent Watermark

Pub. Number AU-A-2007299846

PCT Pub. Number WO2008/036691

Priority 60/845,600 19.09.06 US

Filing date 18 September 2007

Wipo publication date 27 March 2008

International Classifications

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036691 Priority application(s): WO2008/036691

29 April 2010 Amendment Made

  The nature of the amendment is: Add co-inventor Beecher, Christopher 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299847-Visualizing formation of ablation lesions

2007299843-Optimized antibodies that target HM1.24